Laurance S. Rockefeller pioneered early stage investing in entrepreneurs, including James McDonnell, founder of McDonnell Aircraft Corporation. He funded hundreds of start-ups, initially in aviation, branched out into electronics and biotechnology, and was dedicated to the preservation and conservation of our natural resources.

Venrock proudly continues Laurance Rockefeller's heritage.

"If you want to succeed, you should strike out on new paths rather than travel the worn paths of accepted success."

John D. Rockefeller

"Venrock represents all that is good in the VC world. Venrock was there as our first investor, stayed with us through our IPO and through our acquisition by Johnson and Johnson for $6 billion 20 years later. Venrock provided advice and counsel, steering us in the right direction and providing the foundation for our success. Venrock was there at the beginning and was with us at the end; they were invaluable to Centocor."

Michael Wall
Founder, former CEO and Chairman, Centocor

"Venrock really understands what it takes to build an exceptionally successful biotech company: great people, novel and often under appreciated technology, a clear vision for company strategy and differentiation, a highly ethical approach to business, and patient capital. And with Venrock, that patient capital is leveraged by their thoughtful mentoring and coaching of management teams -- truly added-value venture capital at its best."

William Rastetter, Ph.D.
Founder, former Chairman and CEO, IDEC Pharmaceuticals.

"Venrock blends a knowledge base founded in successes with creativity in shaping the future to enable building important biotech enterprises. They provide biotech leadership with helpful advice and support to navigate a challenging business landscape that is punctuated by scientific, regulatory, competitive, partnering, and financing challenges. The Venrock investment culture has been built over time to adapt, succeed and endure by working with the great entrepreneurs of the future."

Dr. John D. Mendlein
Former CEO, Adnexus Therapeutics

"Venrock walks the talk when it comes to a steadfast commitment to help their companies achieve sustainable success over the long term. Year in year out, through good times and bad, Venrock delivered on their promise to help Qpass build a valuable business."

Chase Franklin
Former President and CEO, Q-Pass

"Venrock is unique in the healthcare sector. They don't follow the latest fad and their commitment to the entrepreneur is unmatched in the industry. They stay with you, work on the strategy and help create novel medicines that will change people's lives. I knew from the beginning that I would go to Venrock. Venrock is the first and last stop for the healthcare entrepreneur."

Peter Hecht
Founder, CEO, Ironwood

"Venrock is an extraordinary investor and Board member. There is no question that their foresight, leadership and experience have been pivotal in each step of Sirna's rebirth and emergence as a market leader in the field of RNAi therapeutics."

Howard Robin
Former CEO, Sirna Therapeutics

"Boston-Power is delivering higher performing, longer lasting and safer notebook computer batteries to a global multi-billion market that's increasingly mobile. We're teaming with Venrock Associates to access their decades-long experience helping young companies execute against their opportunities. Their commitment to innovation -- combined with their track-record of taking on a long-term vision and complemented by their excellent networks -- make Venrock an ideal partner for Boston-Power."

Dr. Christina Lampe-Onnerud
Founder and CEO, Boston Power